AIM ImmunoTech: Ownership Update Filed

TL;DR

Kellner & Deutsch updated their AIM ImmunoTech stake filing - check for ownership changes.

AI Summary

On September 3, 2024, Todd Deutsch and Ted D. Kellner filed an amendment (No. 7) to their Schedule 13D for AIM ImmunoTech Inc. The filing indicates a change in the beneficial ownership of the company's common stock. The specific details of the change in ownership percentage or the exact number of shares acquired or disposed of are not explicitly stated in this excerpt, but the filing is a required disclosure for significant beneficial owners.

Why It Matters

This filing signals a potential shift in control or influence over AIM ImmunoTech Inc., which could impact its strategic direction and stock performance.

Risk Assessment

Risk Level: medium — Schedule 13D filings often precede significant corporate actions or reflect changes in investor sentiment, which can introduce volatility.

Key Numbers

• 7 — Amendment Number (Indicates this is the seventh update to the ownership filing.)
• September 3, 2024 — Filing Date (The date the amendment was filed with the SEC.)

Key Players & Entities

• AIM ImmunoTech Inc. (company) — Subject Company
• Todd Deutsch (person) — Filing Person
• Ted D. Kellner (person) — Filing Person
• Baker & Hostetler LLP (company) — Legal Counsel
• John J. Harrington (person) — Authorized Contact

FAQ

Key Financial Figures

• $0.001 — me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti

Filing Documents

• d854691dsc13da.htm (SC 13D/A) — 46KB
• d854691dex991.htm (EX-99.1) — 105KB
• d854691dex992.htm (EX-99.2) — 19KB
• 0001193125-24-212450.txt ( ) — 171KB

is

Item 4 is hereby supplemented as follows: In accordance with the requirements of the Companys bylaws, on September 3, 2024, Mr. Kellner submitted to the Company notice (the Notice) of his intent to nominate himself, Mr. Deutsch and Mr. Chioini for election to the Companys board of directors at the 2024 annual meeting of stockholders. Mr. Kellner also notified the Company that he would supplement the Notice no later than September 13, 2024 to identify an additional highly qualified and independent nominee. The Notice, together with this Schedule 13D, the proxy statement filed by the Reporting Persons and Mr. Chioini last year and the extensive factual record gained through discovery and trial in the Delaware Court of Chancery last year, provides the board with all information it could possibly desire in connection with Mr. Kellners nominations. The Companys stockholders expressed their clear will in connection with last years annual meeting, delivering proxies sufficient to elect the Reporting Persons (despite the fact that the Company did not even include Mr. Kellner, Mr. Deutsch and Mr. Chioini on its proxy card).Against this backdrop, any rejection of the Notice by the board this year would be a clear and obvious bad faith act and continuation of its improper purpose and breach of duty of loyalty. The Reporting Persons are attaching a copy of the Notice as Exhibit 1 hereto. The Reporting Persons intend to focus on pursuing Mr. Kellners nominations in order to effect much needed changes to the Companys board of directors. However, as stockholders of the Company, it has also become increasingly apparent to the Reporting Persons over time that change is also needed with respect to the Companys senior management. In particular, after being found by the Delaware Supreme Court, along with other directors, to have breached his fiduciary duty of loyalty to the Company and its stockholders, and causing severe damage to the Companys financial condition and reputatio

is hereby supplemented as follows

Item 6 is hereby supplemented as follows: The Reporting Persons and Mr. Chioini entered into an agreement, dated September 3, 2024 (the Agreement). The Agreement reflects the agreements of the parties to be named as nominees of Mr. Kellner and to serve as directors if elected or appointed and to act together with respect to the Notice, the proxy solicitation in support of the nominations and other related actions. The Agreement generally provides that the parties will coordinate their activities and communications relating to the Company and will not take specified actions without the agreement of Mr. Kellner. In addition, the parties made representations as to their respective beneficial ownership of Company securities and agreed not to buy, sell, pledge or otherwise acquire or dispose of any Company securities without the consent of the other parties. The Agreement provides that Mr. Kellner will be responsible for expenses incurred in connection with the coordinated activities with respect to the Company, and the other parties will not incur expenses without Mr. Kellners agreement. The foregoing summary is qualified by reference in its entirety by the terms and conditions of the Agreement, a copy of which is attached hereto as Exhibit 2. Item7. Material to be Filed as Exhibits

is hereby supplemented by adding the following exhibits

Item 7 is hereby supplemented by adding the following exhibits: Exhibit No. Name 1. Nomination Notice of Mr. Kellner, dated September 3, 2024 2. Agreement, dated September 3, 2024

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned hereby certifies that the information set forth in this statement is true, complete and correct. Date: September 3, 2024 TODD DEUTSCH By: /s/ Todd Deutsch TED D. KELLNER By: /s/ Ted D. Kellner

View Full Filing

View this SC 13D/A filing on SEC EDGAR